Abstract: Xiangyun Zhu,1,2,* Han Yin,1,2,* Jing Han,1,2,* Xiaoyan Zhang,1,2 Qing Han,1,2 Weixia Sun,1,2 Yijun Liu,1,2 Wenxuan Tao,1,2 Xinliang Liu,3 Guofeng Wang,4 Ling Li1,2 1Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, Peopleâs Republic of China; 2Pancreatic Research Institute, Southeast University, Nanjing, Jiangsu, 210009, Peopleâs Republic of China; 3Department of Endocrinology, Lianyungang Affiliated Hospital of Nanjing Medical University, Lianyungang, 222000, Peopleâs Republic of China; 4Department of Endocrinology, Xuyi Peopleâs Hospital of Clinical College of Yangzhou University, Huaiâan, Jiangsu, 211700, Peopleâs Republic of China*These authors contributed equally to this workCorrespondence: Ling Li, Email dr_liling@126.com; Guofeng Wang, Email wgfyyx@163.comBackground: Patients with type 2 diabetes mellitus (T2DM) exhibit an elevated risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD). The uric acid to high-density lipoprotein cholesterol ratio (UHR) has emerged as a novel metabolic biomarker implicated in MASLD pathogenesis. This study aimed to evaluate the association between UHR and MASLD in a T2DM population.Methods: In this cross-sectional study, we analyzed clinical data from 1081 T2DM patients (464 without MASLD, 617 with MASLD). Physiological and biochemical parameters were collected and analyzed. UHR was calculated as [uric acid (mg/dL)/HDL-C (mg/dL)]âÃâ 100%. Univariate and multivariate logistic regression analyses were performed to examine the association between UHR and MASLD.Results: T2DM patients with MASLD had significantly higher UHR levels than those without MASLD (12.12[9.06â 16.83] vs 10.36[7.65â 14.08], p< 0.001). UHR showed a strong positive correlation with TG/HDL (r =0.673, p < 0.001), moderate correlations with TG (r = 0.516, p < 0.001) and TC/HDL (r =0.548, p < 0.001), weak bu
No Comments.